DK2588609T3 - METHOD AND KIT FOR SEQUENTIAL ISOLATION OF NUCLEOTIDE SPECIES FROM A SAMPLE - Google Patents
METHOD AND KIT FOR SEQUENTIAL ISOLATION OF NUCLEOTIDE SPECIES FROM A SAMPLE Download PDFInfo
- Publication number
- DK2588609T3 DK2588609T3 DK11801242.6T DK11801242T DK2588609T3 DK 2588609 T3 DK2588609 T3 DK 2588609T3 DK 11801242 T DK11801242 T DK 11801242T DK 2588609 T3 DK2588609 T3 DK 2588609T3
- Authority
- DK
- Denmark
- Prior art keywords
- nucleic acid
- dna
- rna
- buffer
- solid phase
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 64
- 238000002955 isolation Methods 0.000 title claims description 11
- 239000002773 nucleotide Substances 0.000 title description 11
- 108020004414 DNA Proteins 0.000 claims description 162
- 102000053602 DNA Human genes 0.000 claims description 153
- 229920002477 rna polymer Polymers 0.000 claims description 87
- 102000039446 nucleic acids Human genes 0.000 claims description 74
- 108020004707 nucleic acids Proteins 0.000 claims description 74
- 150000007523 nucleic acids Chemical class 0.000 claims description 74
- 239000007790 solid phase Substances 0.000 claims description 43
- 239000011534 wash buffer Substances 0.000 claims description 33
- 239000007787 solid Substances 0.000 claims description 31
- 230000027455 binding Effects 0.000 claims description 30
- 239000006166 lysate Substances 0.000 claims description 29
- 239000012148 binding buffer Substances 0.000 claims description 21
- 239000012472 biological sample Substances 0.000 claims description 18
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims description 16
- 239000012149 elution buffer Substances 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 15
- 108010067770 Endopeptidase K Proteins 0.000 claims description 13
- 239000000872 buffer Substances 0.000 claims description 13
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 12
- 239000007983 Tris buffer Substances 0.000 claims description 11
- 230000009089 cytolysis Effects 0.000 claims description 11
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 11
- 102000007260 Deoxyribonuclease I Human genes 0.000 claims description 8
- 108010008532 Deoxyribonuclease I Proteins 0.000 claims description 8
- 150000001298 alcohols Chemical class 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 8
- 230000003196 chaotropic effect Effects 0.000 claims description 8
- 229960004198 guanidine Drugs 0.000 claims description 8
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims description 7
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 7
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims description 7
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 7
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 7
- 230000002378 acidificating effect Effects 0.000 claims description 6
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 229910020175 SiOH Inorganic materials 0.000 claims description 3
- 239000013078 crystal Substances 0.000 claims description 3
- 238000000265 homogenisation Methods 0.000 claims description 2
- 238000003776 cleavage reaction Methods 0.000 claims 4
- 230000007017 scission Effects 0.000 claims 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 108
- 239000000377 silicon dioxide Substances 0.000 description 53
- 241000282414 Homo sapiens Species 0.000 description 39
- 241000894007 species Species 0.000 description 34
- 239000011159 matrix material Substances 0.000 description 33
- 239000011324 bead Substances 0.000 description 31
- 239000000243 solution Substances 0.000 description 26
- 210000001519 tissue Anatomy 0.000 description 26
- 239000012139 lysis buffer Substances 0.000 description 25
- 238000010828 elution Methods 0.000 description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 210000001072 colon Anatomy 0.000 description 17
- 238000011084 recovery Methods 0.000 description 17
- 239000006249 magnetic particle Substances 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 229960001484 edetic acid Drugs 0.000 description 11
- 238000005406 washing Methods 0.000 description 11
- 239000000523 sample Substances 0.000 description 10
- 239000012620 biological material Substances 0.000 description 9
- 125000003729 nucleotide group Chemical group 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- 108010053770 Deoxyribonucleases Proteins 0.000 description 8
- 102000016911 Deoxyribonucleases Human genes 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 210000002741 palatine tonsil Anatomy 0.000 description 8
- 238000002123 RNA extraction Methods 0.000 description 7
- 230000004570 RNA-binding Effects 0.000 description 7
- 238000011109 contamination Methods 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 230000000717 retained effect Effects 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 230000002441 reversible effect Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 206010006187 Breast cancer Diseases 0.000 description 5
- 208000026310 Breast neoplasm Diseases 0.000 description 5
- -1 NaCIC>4 Chemical compound 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 229910000831 Steel Inorganic materials 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 238000000227 grinding Methods 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000010959 steel Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 101000686547 Arabidopsis thaliana 30S ribosomal protein S1, chloroplastic Proteins 0.000 description 4
- 230000004568 DNA-binding Effects 0.000 description 4
- 101001125551 Homo sapiens Ribose-phosphate pyrophosphokinase 1 Proteins 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 239000013614 RNA sample Substances 0.000 description 4
- 102100029508 Ribose-phosphate pyrophosphokinase 1 Human genes 0.000 description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 4
- 239000007984 Tris EDTA buffer Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 229960000789 guanidine hydrochloride Drugs 0.000 description 4
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 229910052710 silicon Inorganic materials 0.000 description 4
- 239000010703 silicon Substances 0.000 description 4
- 238000004513 sizing Methods 0.000 description 4
- 239000013076 target substance Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 108700024394 Exon Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000010240 RT-PCR analysis Methods 0.000 description 3
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 3
- 229940038773 trisodium citrate Drugs 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 230000006862 enzymatic digestion Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000001821 nucleic acid purification Methods 0.000 description 2
- 238000002205 phenol-chloroform extraction Methods 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000007862 touchdown PCR Methods 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- BHNQPLPANNDEGL-UHFFFAOYSA-N 2-(4-octylphenoxy)ethanol Chemical compound CCCCCCCCC1=CC=C(OCCO)C=C1 BHNQPLPANNDEGL-UHFFFAOYSA-N 0.000 description 1
- 108091032955 Bacterial small RNA Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 101150020418 PRPS1 gene Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 description 1
- SAQSTQBVENFSKT-UHFFFAOYSA-M TCA-sodium Chemical compound [Na+].[O-]C(=O)C(Cl)(Cl)Cl SAQSTQBVENFSKT-UHFFFAOYSA-M 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000012776 robust process Methods 0.000 description 1
- 238000007480 sanger sequencing Methods 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- BAZAXWOYCMUHIX-UHFFFAOYSA-M sodium perchlorate Chemical compound [Na+].[O-]Cl(=O)(=O)=O BAZAXWOYCMUHIX-UHFFFAOYSA-M 0.000 description 1
- 229910001488 sodium perchlorate Inorganic materials 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1000701 | 2010-06-29 | ||
| SE1100480 | 2010-11-22 | ||
| PCT/SE2011/050848 WO2012002887A1 (en) | 2010-06-29 | 2011-06-27 | Method and kit for sequential isolation of nucleotide species from a sample |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2588609T3 true DK2588609T3 (en) | 2018-03-19 |
Family
ID=45402362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11801242.6T DK2588609T3 (en) | 2010-06-29 | 2011-06-27 | METHOD AND KIT FOR SEQUENTIAL ISOLATION OF NUCLEOTIDE SPECIES FROM A SAMPLE |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8889393B2 (enExample) |
| EP (1) | EP2588609B1 (enExample) |
| DK (1) | DK2588609T3 (enExample) |
| ES (1) | ES2665012T3 (enExample) |
| NO (1) | NO2588609T3 (enExample) |
| PL (1) | PL2588609T3 (enExample) |
| PT (1) | PT2588609T (enExample) |
| WO (1) | WO2012002887A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012253345B2 (en) | 2011-05-12 | 2016-10-20 | Exact Sciences Corporation | Isolation of nucleic acids |
| US8808990B2 (en) | 2011-05-12 | 2014-08-19 | Exact Sciences Corporation | Serial isolation of multiple DNA targets from stool |
| US8993341B2 (en) | 2011-05-12 | 2015-03-31 | Exact Sciences Corporation | Removal of PCR inhibitors |
| US8980107B2 (en) | 2011-05-12 | 2015-03-17 | Exact Sciences Corporation | Spin filter |
| JP6096774B2 (ja) * | 2011-08-12 | 2017-03-15 | キアゲン ゲゼルシャフト ミット ベシュレンクテル ハフツング | 核酸を単離するための方法 |
| US9670479B2 (en) | 2013-03-15 | 2017-06-06 | F Cubed, LLC | Sample preparation device and methods of use |
| AU2014305085A1 (en) * | 2013-08-05 | 2016-02-25 | The Johns Hopkins University | Fabrication of hierarchical silica nanomembranes and uses thereof for solid phase extraction of nucleic acids |
| SG11201609008PA (en) | 2014-04-29 | 2016-11-29 | Accudx Corp | A novel affinity matrix and devices for isolation and purification of rna and dna for point of care molecular devices |
| EP2942394A1 (en) * | 2014-05-09 | 2015-11-11 | Molzym GmbH & Co. KG | New method for isolating microbial DNA |
| US20160010081A1 (en) * | 2014-07-11 | 2016-01-14 | Exact Sciences Corporation | Systems, methods and kits for extracting nucleic acid from digestive fluid |
| WO2016123101A1 (en) | 2015-01-27 | 2016-08-04 | Circulomics Inc. | Hierarchical silica lamella for magnetic nucleic acid extraction |
| US11242518B2 (en) | 2015-09-04 | 2022-02-08 | QIAGEN Sciences, LLP | Methods for co-isolation of nucleic acids and proteins |
| US10704081B2 (en) * | 2015-10-30 | 2020-07-07 | Exact Sciences Development Company, Llc | Multiplex amplification detection assay |
| CN112313344A (zh) | 2018-04-24 | 2021-02-02 | 凯杰科技有限公司 | 从复杂样品中分离核酸并去除抑制剂 |
| WO2019209600A1 (en) | 2018-04-24 | 2019-10-31 | Qiagen Sciences Llc | Biomolecule isolation and inhibitor removal |
| WO2019207168A1 (en) | 2018-04-27 | 2019-10-31 | Qiagen Gmbh | Method for isolating nucleic acids from plant samples |
| AU2019266454B9 (en) | 2018-05-11 | 2025-09-18 | Qiagen Gmbh | Lysis method for plant samples |
| WO2020069385A1 (en) * | 2018-09-28 | 2020-04-02 | Beckman Coulter, Inc. | Isolation of dna and rna from a single sample |
| WO2023198909A1 (en) * | 2022-04-15 | 2023-10-19 | Quantoom Biosciences S.A. | Methods for separation and/or purification of nucleic acids |
| WO2025046144A1 (en) | 2023-09-01 | 2025-03-06 | Qiagen Gmbh | Method for isolating rna from inhibitor rich samples |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5990301A (en) | 1994-02-07 | 1999-11-23 | Qiagen Gmbh | Process for the separation and purification of nucleic acids from biological sources |
| DK1146049T3 (da) | 1994-02-11 | 2005-12-12 | Qiagen Gmbh | Fremgangsmåde til separering af dobbeltstrengede/enkeltstrengede nucleinsyrestrukturer |
| GB9425138D0 (en) * | 1994-12-12 | 1995-02-08 | Dynal As | Isolation of nucleic acid |
| JP2002502856A (ja) * | 1998-02-04 | 2002-01-29 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | 核酸の単離および精製方法 |
| WO2003046146A2 (en) * | 2001-11-28 | 2003-06-05 | Applera Corporation | Compositions and methods of selective nucleic acid isolation |
| CA2473376A1 (en) | 2002-01-16 | 2003-07-31 | Dynal Biotech Asa | Method for isolating nucleic acids and protein from a single sample |
| GB0215185D0 (en) | 2002-07-01 | 2002-08-07 | Genovision As | Binding a target substance |
| WO2004108925A1 (en) * | 2003-06-04 | 2004-12-16 | Qiagen As | Method for sequentially isolating dna and rna from the same nucleic acid-containing sample |
| DE10358137A1 (de) | 2003-12-12 | 2005-07-07 | Merck Patent Gmbh | Verfahren und Kit zur Isolierung von RNA |
| DE102006031764B4 (de) | 2006-07-06 | 2009-10-01 | Aj Innuscreen Gmbh | Verfahren zur parallelen Isolierung doppel- und einzelsträngiger Nukleinsäuren sowie zur selektiven Entfernung doppelsträngiger Nukleinsäuren aus einem Gemisch von doppel- und einzelsträngigen Nukleinsäuren |
| GB2443505B (en) | 2006-09-26 | 2008-12-31 | Ge Healthcare Bio Sciences | Nucleic acid purification method |
| GB2445441B (en) | 2006-09-26 | 2010-06-30 | Ge Healthcare Bio Sciences | Nucleic acid purification method |
| GB2445442A (en) | 2006-09-26 | 2008-07-09 | Ge Healthcare Bio Sciences | Nucleic acid purification using anion exchange |
| US8067580B2 (en) | 2008-02-07 | 2011-11-29 | Ge Healthcare Bio-Sciences Corp. | Isolation of DNA, RNA and protein from a single sample |
| WO2009134652A1 (en) * | 2008-04-30 | 2009-11-05 | Ge Healthcare Bio-Sciences Corp. | Method for separation of double-stranded and single-stranded nucleic acids |
-
2011
- 2011-06-27 WO PCT/SE2011/050848 patent/WO2012002887A1/en not_active Ceased
- 2011-06-27 DK DK11801242.6T patent/DK2588609T3/en active
- 2011-06-27 US US13/704,739 patent/US8889393B2/en active Active
- 2011-06-27 NO NO11801242A patent/NO2588609T3/no unknown
- 2011-06-27 EP EP11801242.6A patent/EP2588609B1/en active Active
- 2011-06-27 ES ES11801242.6T patent/ES2665012T3/es active Active
- 2011-06-27 PT PT118012426T patent/PT2588609T/pt unknown
- 2011-06-27 PL PL11801242T patent/PL2588609T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2665012T3 (es) | 2018-04-24 |
| US8889393B2 (en) | 2014-11-18 |
| EP2588609A1 (en) | 2013-05-08 |
| PT2588609T (pt) | 2018-04-02 |
| PL2588609T3 (pl) | 2018-06-29 |
| NO2588609T3 (enExample) | 2018-06-16 |
| EP2588609A4 (en) | 2014-03-26 |
| US20130164819A1 (en) | 2013-06-27 |
| WO2012002887A1 (en) | 2012-01-05 |
| EP2588609B1 (en) | 2018-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2588609T3 (en) | METHOD AND KIT FOR SEQUENTIAL ISOLATION OF NUCLEOTIDE SPECIES FROM A SAMPLE | |
| JP6689251B2 (ja) | Ｒｎａを高収率で単離するための方法 | |
| CA2725631C (en) | Method for isolating nucleic acids | |
| ES2470621T3 (es) | Procedimiento para obtener ARN corto as� como kit para el mismo | |
| JP5390772B2 (ja) | 核酸を安定化試薬から精製するための組成物および方法 | |
| CN101979539B (zh) | 用于分离纯化的rna的试剂和方法 | |
| US10323241B2 (en) | Method for recovering short-chain nucleic acids | |
| WO2008115708A1 (en) | Methods for the separation of biological molecules using sulfolane | |
| US10829758B2 (en) | Automatable method for nucleic acid isolation | |
| EP4163371A1 (en) | Nucleic acid extraction method and application | |
| EP2041316A2 (en) | A method of modifying a macromolecule without prior extraction from a sample | |
| US10144951B2 (en) | Method and materials to deplete impurities for extraction and purification of nucleic acids from stool | |
| US20090088560A1 (en) | Process for Nucleic Acid Purification | |
| Jarallah et al. | Design of a new rapid and efficient kit for extracting DNA from blood sample | |
| Göktürk et al. | RNA Purification | |
| HK40085645A (en) | Automatable method for nucleic acid isolation | |
| Florczak et al. | DNA isolation method from human blood with MasterPure DNA Purification Kit™–review article | |
| JP2004105009A (ja) | テトラフェニルホウ素化合物から成る核酸分離用試薬とそれを用いる核酸分離方法 | |
| US20180208923A1 (en) | Method for the selective size-fractionated separation and isolation of nucleic acid mixtures | |
| WO2012014694A1 (ja) | 糞便由来核酸の合成方法 |